Florida’s Marijuana Market: Fierce Expansion Amidst Uncertain Future
With Florida’s marijuana market nearing the $2 billion mark and the possibility of adult-use legalization on the horizon, multistate operators are racing to expand their retail presence. However, the decision to invest in Florida’s cannabis retail landscape is proving to be a high-stakes gamble.
As the competition in Florida’s rapidly growing marijuana market intensifies, medical cannabis dispensaries are already luring in customers with substantial discounts. The state’s market, one of the largest in the nation, boasts over 800,000 registered medical consumers. Yet, some companies are reporting stagnant sales in the quarter that ended on June 30.
The stage is set for even more rivals to enter the arena. Presently, Florida’s medical market has 22 licensed companies, and two more licenses have recently been granted to Black cultivators. Moreover, a fresh batch of 22 vertically integrated Medical Marijuana Treatment Centers (MMTCs) are under regulatory review, signaling an influx of new players.
The prospect of adult-use legalization remains uncertain. While some MMJ operators are striving for its realization, Florida’s attorney general is attempting to block the issue from reaching the November 2024 ballot. This hurdle, however, hasn’t dampened the enthusiasm of MMJ companies as they continue to expand their retail networks.
In a notable move, Verano Holdings, based in Chicago, marked the opening of its 70th dispensary in July, securing the second position in store counts after Florida’s own Trulieve Cannabis and ahead of Ayr Wellness and Curaleaf Holdings. Curaleaf, headquartered in New York, is gearing up for further expansion within the state this year. Meanwhile, Miami-based Ayr has fulfilled its goal of unveiling 10 new dispensaries in 2023, with plans to launch an additional two to four before year-end.
Even the market leader, Trulieve, is keeping pace with its expansion strategy. The company has added three more stores this year, bringing the total count to 126 as of August 11, according to the Florida Department of Health’s Office of Medical Marijuana Use (OMMU). While Florida imposes limits on MMTC licenses, there are no caps on the number of dispensaries licensees can establish.
Although the prevalence of discounts and promotions could indicate market saturation, operators argue that the store-saturation point has not been reached, particularly if adult-use sales become legal. Verano, for instance, reported flat sales in Florida for the quarter ending in June but refrained from matching the steep discounts offered by competitors. Despite the challenges, operators maintain that new stores contribute to long-term growth, even though the timeframe for noticeable accretion has extended.
Curaleaf’s CEO, Matt Darin, highlighted the company’s commitment to expanding its Florida footprint throughout 2023. Instead of merely matching discounts, Curaleaf has chosen to diversify its offerings and brands. Ayr, too, is expanding its product range, recently incorporating edibles brand Kiva Confections into its Florida stores.
While the medical cannabis market’s growth rate has slowed compared to the previous year, it remains on an upward trajectory. The 2023 MJBiz Factbook projects the market to swell from $1.75 billion in 2023 to $2.4 billion by 2026. Active patient numbers have risen by over 7% since January, reaching 838,470, as reported by the OMMU.
The expansion into state medical marijuana markets in preparation for potential adult-use markets is a tried-and-true tactic for cannabis operators. Maryland witnessed a similar scramble as MMJ operators rushed to establish dispensaries ahead of the July 1 launch of adult-use sales. Yet, the situation in Florida remains uncertain. Trulieve, a major player, has contributed nearly $40 million to the Smart & Safe Florida adult-use legalization campaign, which collected ample signatures to place the amendment on the November 2024 ballot.
However, the push faces opposition from the attorney general, the Florida Chamber of Commerce, and the Drug Free America Foundation. These entities label the effort as unconstitutional and Trulieve as seeking a “monopolistic stranglehold” on the adult-use market. The debate centers on whether the amendment misleads voters about sales and federal legality. Trulieve, confident in the clarity of the ballot language, maintains that Florida’s voters should decide on the matter.
The uncertainty surrounding adult-use legalization drives Verano’s focus on the MMJ market’s sustainability. Ayr, in contrast, is positioning itself for the potential adult-use future by strategically opening dispensaries in Miami-Dade and Broward counties. The company bets that these investments will pay off if the state embraces adult-use sales. Despite the uncertainties, Florida’s marijuana market remains a dynamic and evolving landscape that promises both challenges and opportunities for multistate operators.
